Ask AI
ProCE Banner Activity

VEXAS Syndrome Revealed: What HCPs Need to Know to Recognize and Effectively Manage Patients With Hemato-Inflammatory Clinical Manifestations

Slideset

VEXAS syndrome is an acquired autoinflammatory, hematologic genetic condition that affects approximately 1 million people worldwide. Access these slides to gain expert insights on identifying VEXAS syndrome, diagnosing it by ruling out other mimicking diseases, individualizing treatment strategies with glucocorticoids and steroid-sparing therapies, and leveraging a multidisciplinary care team for symptom management to improve outcomes.

Released: November 09, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported by Sobi, Inc.

Sobi, Inc.

Target Audience

This education is intended for rheumatologists, dermatologists, hematologists, nurse practitioners, and physician associates who manage patients with hemato-inflammatory clinical manifestations.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain the pathophysiology of VEXAS syndrome to patients and colleagues

  • Identify and diagnose patients with unexplained hemato-inflammatory manifestations who may have VEXAS syndrome

  • Collaborate with others on the multidisciplinary team caring for patients with VEXAS syndrome to align treatment with evolving best practices and improve outcomes

  • Develop strategies to integrate evolving approaches for VEXAS syndrome into clinical practice to improve patient outcomes and quality of life